[HTML][HTML] Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report
J Chen, J Wang, Y Zou - Medicine, 2021 - journals.lww.com
Interventions: The patient received gemcitabine plus cisplatin as first line treatment, and
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report
J Chen, J Wang, Y Zou - Medicine, 2021 - pubmed.ncbi.nlm.nih.gov
Rationale Squamous cell lung cancer is one of the major pathological types in patients with
non-small cell lung cancer. Since treatment with angiogenic agents and target drugs in …
non-small cell lung cancer. Since treatment with angiogenic agents and target drugs in …
[HTML][HTML] Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report
J Chen, J Wang, Y Zou - Medicine, 2021 - ncbi.nlm.nih.gov
Interventions: The patient received gemcitabine plus cisplatin as first line treatment, and
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report.
J Chen, J Wang, Y Zou - Medicine, 2021 - europepmc.org
Interventions The patient received gemcitabine plus cisplatin as first line treatment, and
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
[HTML][HTML] Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report
J Chen, J Wang, Y Zou - Medicine, 2021 - journals.lww.com
Interventions: The patient received gemcitabine plus cisplatin as first line treatment, and
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …
gemcitabine as maintenance therapy. After progression, she received vinorelbine as second …